James Howe

Dr. James Howe, a surgical oncologist at the University of Iowa, shares insights on neuroendocrine tumors and the vital role of mentorship in his field. He discusses the MEN1 genetic test for assessing cancer risk and the intricacies of diagnosing small bowel tumors. The conversation shifts to histotripsy as a non-invasive treatment for liver lesions and highlights advancements in PRRT for neuroendocrine tumors, emphasizing personalized treatment strategies. Howe also addresses patient concerns about medication transitions and the challenges of participating in clinical trials.